Myocarditis: Difference between revisions
Homa Najafi (talk | contribs) No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
(5 intermediate revisions by the same user not shown) | |||
Line 3: | Line 3: | ||
'''For the WikiPatient page for this topic, click [[{{PAGENAME}} (patient information)|here]]''' | '''For the WikiPatient page for this topic, click [[{{PAGENAME}} (patient information)|here]]''' | ||
'''Editors-In-Chief:''' [[C. Michael Gibson|C. Michael Gibson, M.S., M.D.]] [mailto:charlesmichaelgibson@gmail.com]; '''Associate Editor(s)-In-Chief: ''' [[Varun Kumar|Varun Kumar, M.B.B.S.]]; {{CZ}}; {{Maliha | '''Editors-In-Chief:''' [[C. Michael Gibson|C. Michael Gibson, M.S., M.D.]] [mailto:charlesmichaelgibson@gmail.com]; '''Associate Editor(s)-In-Chief: ''' {{Homa}}[[Varun Kumar|Varun Kumar, M.B.B.S.]]; {{CZ}}; {{Maliha}} | ||
{{SK}} [[Inflammatory cardiomyopathy]]; [[Idiopathic myocarditis]]; [[Viral cardiomyopathy]]; [[inflammation of the heart muscle]]; [[myocardium inflammation]]; [[bacterial myocarditis]]; [[viral myocarditis]]; [[fungal myocarditis]]; [[spirochaetal myocarditis]]; [[protozoal myocarditis]]; [[parasitic myocarditis]]; [[rickettsial myocarditis]]; [[autoimmune myocarditis]]; [[immune-mediated myocarditis]]; [[allergen-mediated myocarditis]]; [[alloantigen-mediated myocarditis]]; [[autoantigen-mediated myocarditis]]; [[toxic myocarditis]]; [[dug-mediated myocarditis]]; [[drug-related myocarditis]]; [[acute myocarditis]]; [[chronic myocarditis]]; [[sarcoidosis-related myocarditis]]; [[giant cell myocarditis]]; [[autoreactive myocarditis]]; [[healed myocarditis]]; [[pediatric myocarditis]]; [[myocarditis in children]]; [[children myocarditis]]; [[pediatric inflammatory cardiomyopathy]]; [[pediatric inflammation of heart muscle]]; [[Inflammatory cardiomyopathy in children]]; [[inflammation of the heart muscle in children]]; [[Postviral autoimmune-related myocarditis]]; [[Infectious myocarditis]]; [[hypersensitivity myocarditis]] | {{SK}} [[Inflammatory cardiomyopathy]]; [[Idiopathic myocarditis]]; [[Viral cardiomyopathy]]; [[inflammation of the heart muscle]]; [[myocardium inflammation]]; [[bacterial myocarditis]]; [[viral myocarditis]]; [[fungal myocarditis]]; [[spirochaetal myocarditis]]; [[protozoal myocarditis]]; [[parasitic myocarditis]]; [[rickettsial myocarditis]]; [[autoimmune myocarditis]]; [[immune-mediated myocarditis]]; [[allergen-mediated myocarditis]]; [[alloantigen-mediated myocarditis]]; [[autoantigen-mediated myocarditis]]; [[toxic myocarditis]]; [[dug-mediated myocarditis]]; [[drug-related myocarditis]]; [[acute myocarditis]]; [[chronic myocarditis]]; [[sarcoidosis-related myocarditis]]; [[giant cell myocarditis]]; [[autoreactive myocarditis]]; [[healed myocarditis]]; [[pediatric myocarditis]]; [[myocarditis in children]]; [[children myocarditis]]; [[pediatric inflammatory cardiomyopathy]]; [[pediatric inflammation of heart muscle]]; [[Inflammatory cardiomyopathy in children]]; [[inflammation of the heart muscle in children]]; [[Postviral autoimmune-related myocarditis]]; [[Infectious myocarditis]]; [[hypersensitivity myocarditis]]; [[fulminant myocarditis]], [[eosinophilic myocarditis]] | ||
==[[Myocarditis overview|Overview]]== | ==[[Myocarditis overview|Overview]]== | ||
Line 27: | Line 27: | ||
==Treatment== | ==Treatment== | ||
[[Myocarditis medical therapy|Medical Therapy]] | [[Myocarditis | [[Myocarditis medical therapy|Medical Therapy]] | [[Myocarditis surgery|Surgery]] | [[Myocarditis primary prevention|Primary Prevention]] | [[Myocarditis secondary prevention|Secondary Prevention]] | [[Myocarditis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Myocarditis future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== |
Latest revision as of 15:23, 15 June 2020
Myocarditis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Myocarditis On the Web |
American Roentgen Ray Society Images of Myocarditis |
For the WikiPatient page for this topic, click here
Editors-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Homa Najafi, M.D.[2]Varun Kumar, M.B.B.S.; Cafer Zorkun, M.D., Ph.D. [3]; Maliha Shakil, M.D. [4]
Synonyms and keywords: Inflammatory cardiomyopathy; Idiopathic myocarditis; Viral cardiomyopathy; inflammation of the heart muscle; myocardium inflammation; bacterial myocarditis; viral myocarditis; fungal myocarditis; spirochaetal myocarditis; protozoal myocarditis; parasitic myocarditis; rickettsial myocarditis; autoimmune myocarditis; immune-mediated myocarditis; allergen-mediated myocarditis; alloantigen-mediated myocarditis; autoantigen-mediated myocarditis; toxic myocarditis; dug-mediated myocarditis; drug-related myocarditis; acute myocarditis; chronic myocarditis; sarcoidosis-related myocarditis; giant cell myocarditis; autoreactive myocarditis; healed myocarditis; pediatric myocarditis; myocarditis in children; children myocarditis; pediatric inflammatory cardiomyopathy; pediatric inflammation of heart muscle; Inflammatory cardiomyopathy in children; inflammation of the heart muscle in children; Postviral autoimmune-related myocarditis; Infectious myocarditis; hypersensitivity myocarditis; fulminant myocarditis, eosinophilic myocarditis
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Myocarditis from other Diseases
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Endomyocardial Biopsy | Chest X Ray | MRI | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies